🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

KeyBanc maintains Sector Weight on UHS stock after 3Q EBITDA beat

EditorAhmed Abdulazez Abdulkadir
Published 28/10/2024, 15:04
UHS
-

On Monday, KeyBanc Capital Markets maintained its Sector Weight rating on shares of Universal Health Services (NYSE:UHS), following the company's third-quarter earnings report. The report showed a slight outperformance relative to Wall Street expectations, with a 2% EBITDA beat that was bolstered by higher-than-expected Medicaid supplemental payments.

The hospital sector, including UHS, experienced a decline in stock value on Friday, with shares falling between 7-10% compared to the S&P 500's marginal decrease of 0.03%. According to KeyBanc, this drop may be attributed to a combination of factors. Investors had high hopes for a significant earnings beat and raised guidance, excluding the impact of hurricanes, along with stronger momentum in Acute volume. However, Universal Health Services management had previously indicated that second-half Acute volume comparisons would be challenging.

Additionally, market dynamics ahead of the upcoming election were also cited as a reason for the stock's decline. There is a sentiment that a victory for President Trump could exert pressure on hospital stocks.

KeyBanc's continued Sector Weight rating is based on the company's valuation and recent legal concerns surrounding its Behavioral segment. The rating suggests that KeyBanc views the company's stock as appropriately valued when compared to others in the sector and advises investors that the stock is expected to perform in line with the average returns of the sector.

InvestingPro Insights

Despite the recent stock decline noted in the article, InvestingPro data reveals that Universal Health Services (NYSE:UHS) has demonstrated strong financial performance. The company's P/E ratio of 13.49 suggests it may be undervalued relative to its earnings, especially considering its impressive revenue growth of 9.93% over the last twelve months as of Q3 2024.

InvestingPro Tips highlight that UHS has a perfect Piotroski Score of 9, indicating strong financial health. This aligns with the company's ability to outperform Wall Street expectations as mentioned in the article. Additionally, the tip that management has been aggressively buying back shares suggests confidence in the company's future prospects, potentially offsetting concerns about challenging Acute volume comparisons.

It's worth noting that UHS has maintained dividend payments for 22 consecutive years, demonstrating a commitment to shareholder returns. This could be particularly relevant given the market dynamics and investor sentiment discussed in the article.

For investors seeking a more comprehensive analysis, InvestingPro offers 11 additional tips for UHS, providing a deeper understanding of the company's financial position and market performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.